A more accurate statement would have been something like, "Research as early as the 1950s Indicated that consumption of trans fatty acids can exacerbate a deficiency of cardioprotective essential fatty acids, and a 1975 study demonstrated that trans fatty acids are atherogenic
Results: Compared to the basic diet, the atherogenic
diet decreased the ability of the aorta to relax by 63% (p < 0.
Their results indicated that apo B is the best such predictor, and also that particle concentration of atherogenic
lipoproteins is more crucial than is cholesterol content in the development of CHD (Circulation 2005;112:3375-83).
Prior human data suggest that treatment with VK2809 leads to significant reductions in LDL-C, triglycerides, and atherogenic
To evaluate whether arsenic induces events in endothelial cells relevant to atherogenic
potential, we used HAEC cultures.
Patients were considered to have hypertension if they had blood pressure values [greater than or equal to]140/90 mmHg or were on treatment, and to have atherogenic
dyslipidemia if they had high triglycerides (>1.
Our findings link immune cell activation as a key molecular event in the BaP-induced atherogenic
response," he says.
The non-HDL cholesterol level combines in a single number the levels of highly atherogenic
very-low-density lipoprotein and intermediate-density lipoprotein as well as LDL.
Rx] experienced an 88 percent reduction in apolipoprotein C-III (apoC-III), a 72 percent reduction in triglyceride levels, a 40 percent increase in high-density lipoprotein cholesterol (HDL-C), the 'good' cholesterol, and improvements in other atherogenic
SAN FRANCISCO -- Reducing dietary carbohydrates can improve atherogenic
dyslipidemia, even in the absence of weight loss, Dr.
Partially catabolized TG-rich lipoproteins such as intermediate-density lipoproteins and remnant-like particles (RLP) are considered to be highly atherogenic
This, we believe, is important in terms of helping to reduce the risk of atherogenic
disease in postmenopausal women.
Data from two randomized, placebo-controlled phase 3 trials in patients with HeFH showed that mipomersen reduced Lp(a), LDL-C, and other measures of atherogenic
lipoproteins when added to existing lipid-lowering therapy.
Oxidized LDL is the atherogenic
form of LDL cholesterol linked to the deposition of plaque in the artery walls.
Thus all Apo B--containing lipoproteins can be considered atherogenic